Tofacitinib Shows Promise in Psoriatic Arthritis Tofacitinib Shows Promise in Psoriatic Arthritis

Tofacitinib is better than placebo for psoriatic arthritis that has responded poorly to treatment with conventional disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Source Type: news